Holland & Knight’s Michael Werner talks to Dr. Russell Medford, President and CEO of Salutria Pharmaceuticals, a privately-held biotech company based in Alpharetta Georgia. Dr. Medford is also co-chair of BIO’s Board Standing Committee on Bioethics. Dr. Medford will be providing testimony on Wednesday November 16 to the Presidential Commission for the Study of Bioethical Issues on Principles Regarding Ethical Performance of International Clinical Trials.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
Tagsbiofuels Benefits of biotech crops patent health FDA Sustainability BIO Events climate change Health Care biotechnology Plant biotechnology Biotechnology Industry agriculture healthcare USPTO Intellectual Property BIOTECH biotech industry public policy Food
- Most Popular
Latest VideoHans Schikan, CEO of Prosensa, on Rare Disease Drug Development View All >